ZAP70 (Ab-319) Antibody

What is the biological significance of ZAP70 Y319 phosphorylation in T-cell signaling?

ZAP70 (Zeta-chain-associated protein kinase 70) is a critical tyrosine kinase that plays an essential role in T-cell receptor (TCR) signaling. Phosphorylation of Y319 is particularly significant as it serves as a molecular switch that stabilizes ZAP70 in its active conformation. When antigen-presenting cells activate the TCR, a series of phosphorylation events occurs, leading to ZAP70 recruitment to the doubly phosphorylated TCR component CD247/CD3Z through ITAM motifs at the plasma membrane .

The phosphorylation of Y319 provides several crucial functions:

• It prevents ZAP70 from returning to its autoinhibited conformation

• It creates a docking site for the SH2 domain of Lck, enhancing proximal TCR signaling

• It facilitates the bridging of Lck to ZAP70, which helps localize key substrates like LAT

• It provides positive feedback to amplify TCR signaling

This phosphorylation event is so critical that mutations of Y319 to phenylalanine in mouse models resulted in severe defects in calcium mobilization and thymocyte selection, confirming its essential role in positive regulation of ZAP70 function .

How does Y319 phosphorylation differ functionally from other phosphorylation sites in ZAP70?

ZAP70 contains multiple tyrosine residues that undergo phosphorylation following TCR stimulation, each with distinct regulatory functions:

Y319 is functionally distinct because it serves as a critical docking site for Lck, which provides multiple positive feedback functions: (1) maintaining co-receptor-associated Lck near the stimulated TCR, (2) maintaining Lck in its active conformation, (3) stabilizing ZAP70's active conformation, and (4) facilitating the localization of ZAP70's key substrate LAT .

Mutation studies have demonstrated that Y315 and Y319 together are essential for ZAP70 function - mutation of both to phenylalanine renders the kinase inactive, while mutation to alanine results in increased basal kinase activity . This contrasts with Y292, which has primarily negative regulatory functions.

What are the optimal applications for using anti-phospho ZAP70 (Y319) antibodies in T-cell activation studies?

Anti-phospho ZAP70 (Y319) antibodies are valuable tools for studying T-cell activation through various applications:

The HTRF phospho-ZAP70 (Tyr319) assay provides particular advantages for high-throughput studies, as it enables cell-based quantitative detection of ZAP70 phosphorylation as a direct readout of T-cell activation . This assay uses two labeled antibodies: one with a donor fluorophore specific for the phosphorylated motif, and one with an acceptor that recognizes ZAP70 regardless of phosphorylation state. The FRET signal generated is directly proportional to the concentration of phosphorylated protein .

For spatial studies examining where phosphorylated ZAP70 localizes within the immunological synapse, ICC/IF approaches would be more appropriate, while flow cytometry offers advantages for analyzing phosphorylation in complex cell populations.

What controls should be included when validating anti-phospho ZAP70 (Y319) antibody specificity?

Rigorous validation of phospho-specific antibodies is essential for accurate data interpretation. The following controls should be included:

• Stimulation controls:

  • Unstimulated T cells (negative control)

  • TCR-stimulated T cells (positive control)

  • PMA-stimulated cells (bypass proximal TCR signaling)

• Specificity controls:

  • Phosphatase treatment of lysates (should abolish signal)

  • Competitive blocking with phospho-peptide used as immunogen

  • Y319F mutant ZAP70-expressing cells (should show no signal)

• Cell type controls:

  • ZAP70-deficient cell lines (e.g., P116, a ZAP70-deficient Jurkat-derived T cell line)

  • Reconstituted cells expressing wild-type or mutant ZAP70

• Inhibitor controls:

  • Lck inhibitors (should prevent Y319 phosphorylation)

  • 3-MB-PP1 inhibitor for analog-sensitive ZAP70 (if using AS mutants)

When using phospho-ZAP70 (Y319) antibodies in flow cytometry, researchers should compare results with traditional western blot to confirm specificity. Additionally, for HTRF-based detection methods, appropriate background controls and signal calibration standards should be included to ensure quantitative accuracy .

How can structural insights into ZAP70 Y319 phosphorylation inform the development of more specific antibodies and inhibitors?

Recent structural studies provide critical insights into how Y319 phosphorylation regulates ZAP70 conformation. Crystal structures of ZAP70 have revealed that in the wild-type protein (ZAP-70-YY), the C-terminal part of the SH2-kinase linker adopts a helical conformation that positions Y319 to interact with the N-lobe of the kinase domain . This interaction is crucial for the conformational changes that occur during kinase activation.

The crystal structure of ZAP-70 with intact Y315 and Y319 (3.0-Å resolution, Rfree = 0.288, R = 0.214) revealed a five-residue sequence register error in earlier models based on Y315F/Y319F mutations . This structural insight demonstrates that:

• Y319 interacts with regions of the kinase domain that undergo structural changes during activation/inactivation

• The SH2-kinase linker can suppress ZAP70 activity even when the tandem-SH2 module is displaced

• Y319 phosphorylation can relieve this suppression, allowing full activation

For antibody development, these structural insights suggest that the most specific antibodies would recognize not just the phosphorylated Y319 residue, but also its unique conformational context within the active protein. Researchers should consider using structural information to design synthetic peptide immunogens that mimic the three-dimensional environment of phospho-Y319.

For inhibitor development, the structural data indicates that compounds targeting the interface between phospho-Y319 and its binding partners could selectively modulate ZAP70 function in T cells, potentially offering therapeutic approaches for immunomodulation.

What methodological approaches can distinguish between the direct effects of Y319 phosphorylation and its role as a docking site?

Distinguishing between the structural effects of Y319 phosphorylation on ZAP70 conformation and its role as a protein-protein interaction site requires sophisticated experimental approaches:

• Phosphomimetic mutations:

  • Compare Y319E (mimics phosphorylation) with Y319F (prevents phosphorylation)

  • Assess kinase activity using in vitro kinase assays with purified proteins

  • Measure conformational changes using fluorescence resonance energy transfer (FRET) sensors

• Protein-protein interaction disruption:

  • Use specific peptides that compete for binding to phospho-Y319

  • Create Lck SH2 domain mutants that cannot bind phospho-Y319

  • Employ proximity labeling techniques (BioID, APEX) to identify the complete interactome of phospho-Y319

• Combined approaches:

  • FRET-based LAT phosphorylation assays to monitor ZAP70 activity

  • Fluorescently labeled Grb2 recruitment assays to assess downstream signaling

  • Time-resolved phosphorylation studies using rapid immunoprecipitation and kinase assays

For example, a study used a FRET-based LAT phosphorylation assay where the reaction buffer contained "20 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 150 mM NaCl, 1 μM Alexa Fluor 555-labeled LAT, 1 μM Alexa Fluor 647-labeled Grb2, and 1 μM kinase" . This approach allowed researchers to monitor ZAP70 activity by measuring fluorescence intensity at 670 nm (with excitation at 555 nm) after adding ATP to trigger the reaction.

How should researchers address discrepancies between phospho-ZAP70 (Y319) detection methods in experimental data?

When researchers encounter discrepancies between different detection methods for phospho-ZAP70 (Y319), a systematic troubleshooting approach should be employed:

• Method-specific considerations:

  • Western blot: Check for non-specific bands; confirm molecular weight (70kDa)

  • Flow cytometry: Validate fixation and permeabilization protocols; check for autofluorescence

  • HTRF: Ensure proper donor/acceptor antibody ratios; check for interference from buffer components

• Temporal dynamics:

  • Different methods may have different sensitivities to the rapid kinetics of Y319 phosphorylation

  • Implement time-course experiments with narrow intervals (30 seconds to 5 minutes) after stimulation

  • Compare results across methods at identical time points

• Sample preparation impacts:

  • Lysis buffers may affect phosphatase activity and artificially reduce phosphorylation

  • Always include phosphatase inhibitors (e.g., sodium orthovanadate) in all buffers

  • For cell-based assays, standardize cell density and activation conditions

A comprehensive validation approach is to use multiple antibody clones targeting the same phospho-epitope and comparing results across detection platforms. When discrepancies persist, orthogonal approaches like mass spectrometry-based phosphopeptide analysis can provide definitive confirmation of phosphorylation status.

What are the critical variables that affect phospho-ZAP70 (Y319) detection in different experimental systems?

Several critical variables can significantly impact the detection of phospho-ZAP70 (Y319) across different experimental systems:

For flow cytometry analysis of phosphorylated ZAP70, researchers should consider that "cells were incubated with anti-TCR antibody (1:2000 C305) for a 30-min time course, with vehicle (DMSO) or inhibitor, in a 96-well round bottom plate" . This highlights the importance of standardized stimulation protocols.

For the HTRF assay, the protocol notes that "the 2 plate protocol involves culturing cells in a 96-well plate before lysis then transferring lysates to a 384-well low volume detection plate before adding phospho-ZAP-70 (Tyr319) HTRF detection reagents" . This multi-step process introduces variables at each stage that must be carefully controlled.

How can phospho-ZAP70 (Y319) antibodies be used to investigate T-cell dysfunction in autoimmune diseases?

Phospho-ZAP70 (Y319) antibodies provide valuable tools for investigating T-cell dysfunction in autoimmune conditions through several approaches:

• Diagnostic biomarker development:

  • Flow cytometry analysis of phospho-ZAP70 (Y319) in patient T-cells can reveal altered signaling

  • Comparison of basal vs. stimulated phosphorylation ratios between patient and healthy control samples

  • Correlation of phosphorylation patterns with disease activity scores

• Mechanism investigation:

  • Both hypoactive and hyperactive ZAP70 can lead to autoimmunity through distinct mechanisms

  • Reduced Y319 phosphorylation may indicate defects in positive selection during T-cell development

  • Excessive Y319 phosphorylation could suggest hyperresponsive T-cells contributing to autoimmunity

• Therapeutic monitoring:

  • Tracking changes in ZAP70 Y319 phosphorylation during immunomodulatory therapy

  • Predicting treatment response based on normalization of phosphorylation patterns

  • Identifying patient subgroups with specific ZAP70 signaling abnormalities

Research has established that appropriate ZAP70 activity is critical for proper T-cell development and function, with either too little or too much activity potentially leading to autoimmunity . Therefore, quantitative assessment of Y319 phosphorylation could provide insights into disease mechanisms and treatment strategies.

What experimental designs best capture the dynamic regulation of ZAP70 Y319 phosphorylation in response to therapeutic interventions?

Capturing the dynamic regulation of ZAP70 Y319 phosphorylation in response to therapeutics requires sophisticated experimental designs:

• Real-time phosphorylation monitoring:

  • Live-cell imaging using FRET-based biosensors for ZAP70 phosphorylation

  • Time-lapse flow cytometry with rapid fixation at defined intervals

  • Sequential immunoprecipitation from parallel samples with precise timing

• Dose-response matrices:

  • Test therapeutic compounds at multiple concentrations

  • Examine effects at multiple time points after treatment

  • Create 3D response surfaces (dose × time × phosphorylation)

• Multi-parameter analysis:

  • Combine Y319 phosphorylation with downstream signaling markers (pLAT, pERK)

  • Correlate phosphorylation with functional readouts (CD69 upregulation, cytokine production)

  • Perform single-cell analysis to identify responsive vs. non-responsive populations

For example, researchers studying ZAP70 inhibitors used CD69 upregulation as a functional readout where "cells were incubated with DMSO (vehicle) or inhibitor and stimulated with anti-TCR antibody (1:1000 C305) or phorbol 12-myristate 13-acetate (PMA) (25 ng/ml). Cells were left overnight at 37°C with 5% CO2 and then stained with allophycocyanin-conjugated CD69" . This approach allows researchers to link proximal signaling events (Y319 phosphorylation) with functional outcomes.

For therapeutic intervention studies, researchers should employ analog-sensitive ZAP70 alleles when possible, as these allow highly specific inhibition and can serve as positive controls for drug effects on the ZAP70 pathway .